Real Estate - Services
Compare Stocks
2 / 10Stock Comparison
ALBT vs SNGX
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
ALBT vs SNGX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Services | Biotechnology |
| Market Cap | $379K | $3M |
| Revenue (TTM) | $1M | $0.00 |
| Net Income (TTM) | $-19M | $-11M |
| Gross Margin | 25.7% | — |
| Operating Margin | -5.1% | — |
| Total Debt | $8M | $1M |
| Cash & Equiv. | $3M | $8M |
ALBT vs SNGX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avalon GloboCare Co… (ALBT) | 100 | 0.2 | -99.8% |
| Soligenix, Inc. (SNGX) | 100 | 0.1 | -99.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALBT vs SNGX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALBT is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.11
- Rev growth 6.2%, EPS growth -430.8%, 3Y rev CAGR -1.4%
- -99.6% 10Y total return vs SNGX's -100.0%
SNGX carries the broadest edge in this set and is the clearest fit for quality and momentum.
- 2.4% margin vs ALBT's -13.6%
- -84.4% vs ALBT's -88.9%
- -135.7% ROA vs ALBT's -207.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.2% FFO/revenue growth vs SNGX's -100.0% | |
| Quality / Margins | 2.4% margin vs ALBT's -13.6% | |
| Stability / Safety | Beta 1.11 vs SNGX's 1.97 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -84.4% vs ALBT's -88.9% | |
| Efficiency (ROA) | -135.7% ROA vs ALBT's -207.3% |
ALBT vs SNGX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALBT vs SNGX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ALBT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
ALBT and SNGX operate at a comparable scale, with $1M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1M | $0 |
| EBITDAEarnings before interest/tax | -$7M | -$12M |
| Net IncomeAfter-tax profit | -$19M | -$11M |
| Free Cash FlowCash after capex | -$5M | -$10M |
| Gross MarginGross profit ÷ Revenue | +25.7% | — |
| Operating MarginEBIT ÷ Revenue | -5.1% | — |
| Net MarginNet income ÷ Revenue | -13.6% | — |
| FCF MarginFCF ÷ Revenue | -3.9% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.4% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +96.6% | +25.6% |
Valuation Metrics
Evenly matched — ALBT and SNGX each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $379,329 | $3M |
| Enterprise ValueMkt cap + debt − cash | $5M | -$3M |
| Trailing P/EPrice ÷ TTM EPS | -0.05x | -0.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.28x | — |
| Price / BookPrice ÷ Book value/share | 0.05x | 0.12x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
SNGX leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
ALBT delivers a -109.2% return on equity — every $100 of shareholder capital generates $-109 in annual profit, vs $-3 for SNGX. SNGX carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALBT's 1.10x. On the Piotroski fundamental quality scale (0–9), ALBT scores 7/9 vs SNGX's 2/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -109.2% | -2.7% |
| ROA (TTM)Return on assets | -2.1% | -135.7% |
| ROICReturn on invested capital | -26.6% | — |
| ROCEReturn on capital employed | -47.1% | -2.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 2 |
| Debt / EquityFinancial leverage | 1.10x | 0.36x |
| Net DebtTotal debt minus cash | $5M | -$6M |
| Cash & Equiv.Liquid assets | $3M | $8M |
| Total DebtShort + long-term debt | $8M | $1M |
| Interest CoverageEBIT ÷ Interest expense | -2.02x | — |
Total Returns (Dividends Reinvested)
Evenly matched — ALBT and SNGX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALBT five years ago would be worth $29 today (with dividends reinvested), compared to $10 for SNGX. Over the past 12 months, SNGX leads with a -84.4% total return vs ALBT's -88.9%. The 3-year compound annual growth rate (CAGR) favors SNGX at -73.5% vs ALBT's -75.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -67.6% | -78.3% |
| 1-Year ReturnPast 12 months | -88.9% | -84.4% |
| 3-Year ReturnCumulative with dividends | -98.6% | -98.1% |
| 5-Year ReturnCumulative with dividends | -99.7% | -99.9% |
| 10-Year ReturnCumulative with dividends | -99.6% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -75.7% | -73.5% |
Risk & Volatility
ALBT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ALBT is the less volatile stock with a 1.11 beta — it tends to amplify market swings less than SNGX's 1.97 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALBT currently trades 8.5% from its 52-week high vs SNGX's 4.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 1.97x |
| 52-Week HighHighest price in past year | $4.74 | $6.23 |
| 52-Week LowLowest price in past year | $0.34 | $0.30 |
| % of 52W HighCurrent price vs 52-week peak | +8.5% | +4.9% |
| RSI (14)Momentum oscillator 0–100 | 42.4 | 19.8 |
| Avg Volume (50D)Average daily shares traded | 8.4M | 722K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
ALBT leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). SNGX leads in 1 (Profitability & Efficiency). 2 tied.
ALBT vs SNGX: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — ALBT or SNGX?
Over the past 5 years, Avalon GloboCare Corp.
(ALBT) delivered a total return of -99. 7%, compared to -99. 9% for Soligenix, Inc. (SNGX). Over 10 years, the gap is even starker: ALBT returned -99. 6% versus SNGX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — ALBT or SNGX?
By beta (market sensitivity over 5 years), Avalon GloboCare Corp.
(ALBT) is the lower-risk stock at 1. 11β versus Soligenix, Inc. 's 1. 97β — meaning SNGX is approximately 78% more volatile than ALBT relative to the S&P 500. On balance sheet safety, Soligenix, Inc. (SNGX) carries a lower debt/equity ratio of 36% versus 110% for Avalon GloboCare Corp. — giving it more financial flexibility in a downturn.
03Which is growing faster — ALBT or SNGX?
On earnings-per-share growth, the picture is similar: Soligenix, Inc.
grew EPS 60. 7% year-over-year, compared to -430. 8% for Avalon GloboCare Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — ALBT or SNGX?
Soligenix, Inc.
(SNGX) is the more profitable company, earning 0. 0% net margin versus -592. 7% for Avalon GloboCare Corp. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNGX leads at 0. 0% versus -369. 6% for ALBT. At the gross margin level — before operating expenses — ALBT leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — ALBT or SNGX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is ALBT or SNGX better for a retirement portfolio?
For long-horizon retirement investors, Avalon GloboCare Corp.
(ALBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 11)). Soligenix, Inc. (SNGX) carries a higher beta of 1. 97 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALBT: -99. 6%, SNGX: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between ALBT and SNGX?
These companies operate in different sectors (ALBT (Real Estate) and SNGX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.